|
|
|
|
|
|
|
Table 20. Reported cases of HIV infection (not AIDS) for male adults and adolescents, by transmission category and race/ethnicity, 2005 and cumulative—38 states and U.S. dependent areas with confidential name-based HIV infection reporting |
|
|
View PDF
|
|
|
|
|
|
|
|
|
2005 |
|
Cumulativea |
Transmission category |
No. |
% |
|
No. |
% |
|
White, not Hispanic |
Male-to-male sexual contact |
6,261 |
68 |
|
45,696 |
67 |
Injection drug use |
540 |
6 |
|
4,954 |
7 |
Male-to-male sexual contact and injection drug use |
433 |
5 |
|
4,595 |
7 |
Hemophilia/coagulation disorder |
21 |
0 |
|
343 |
1 |
High-risk heterosexual contactb | 275 |
3 |
|
2,258 |
3 |
Sex with injection drug user |
53 |
1 |
|
501 |
1 |
Sex with person with hemophilia |
0 |
0 |
|
7 |
0 |
Sex with HIV-infected transfusion recipient |
2 |
0 |
|
32 |
0 |
Sex with HIV-infected person, risk factor not specified |
220 |
2 |
|
1,718 |
3 |
Receipt of blood transfusion, blood components, or tissue |
6 |
0 |
|
194 |
0 |
Other/risk factor not reported or identified |
1,681 |
18 |
|
10,336 |
15 |
Total |
9,217 |
100 |
|
68,376 |
100 |
|
|
|
Black, not Hispanic |
Male-to-male sexual contact |
4,020 |
40 |
|
25,186 |
35 |
Injection drug use |
915 |
9 |
|
10,869 |
15 |
Male-to-male sexual contact and injection drug use |
272 |
3 |
|
3,093 |
4 |
Hemophilia/coagulation disorder |
5 |
0 |
|
104 |
0 |
High-risk heterosexual contactb | 1,095 |
11 |
|
9,677 |
13 |
Sex with injection drug user |
105 |
1 |
|
1,454 |
2 |
Sex with person with hemophilia |
2 |
0 |
|
13 |
0 |
Sex with HIV-infected transfusion recipient |
5 |
0 |
|
78 |
0 |
Sex with HIV-infected person, risk factor not specified |
983 |
10 |
|
8,132 |
11 |
Receipt of blood transfusion, blood components, or tissue |
18 |
0 |
|
207 |
0 |
Other/risk factor not reported or identified |
3,667 |
37 |
|
22,720 |
32 |
Total |
9,992 |
100 |
|
71,856 |
100 |
|
|
|
Hispanic |
Male-to-male sexual contact |
2,201 |
44 |
|
12,063 |
44 |
Injection drug use |
1,126 |
22 |
|
5,634 |
21 |
Male-to-male sexual contact and injection drug use |
155 |
3 |
|
1,096 |
4 |
Hemophilia/coagulation disorder |
3 |
0 |
|
24 |
0 |
High-risk heterosexual contactb | 485 |
10 |
|
2,520 |
9 |
Sex with injection drug user |
64 |
1 |
|
413 |
2 |
Sex with person with hemophilia |
0 |
0 |
|
6 |
0 |
Sex with HIV-infected transfusion recipient |
2 |
0 |
|
14 |
0 |
Sex with HIV-infected person, risk factor not specified |
419 |
8 |
|
2,087 |
8 |
Receipt of blood transfusion, blood components, or tissue |
6 |
0 |
|
48 |
0 |
Other/risk factor not reported or identified |
1,079 |
21 |
|
6,073 |
22 |
Total |
5,055 |
100 |
|
27,458 |
100 |
|
|
|
Asian/Pacific Islander |
Male-to-male sexual contact |
128 |
56 |
|
651 |
57 |
Injection drug use |
5 |
2 |
|
45 |
4 |
Male-to-male sexual contact and injection drug use |
6 |
3 |
|
26 |
2 |
Hemophilia/coagulation disorder |
0 |
0 |
|
1 |
0 |
High-risk heterosexual contactb | 18 |
8 |
|
77 |
7 |
Sex with injection drug user |
1 |
0 |
|
9 |
1 |
Sex with person with hemophilia |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected transfusion recipient |
1 |
0 |
|
3 |
0 |
Sex with HIV-infected person, risk factor not specified |
16 |
7 |
|
65 |
6 |
Receipt of blood transfusion, blood components, or tissue |
0 |
0 |
|
4 |
0 |
Other/risk factor not reported or identified |
72 |
31 |
|
333 |
29 |
Total |
229 |
100 |
|
1,137 |
100 |
|
|
|
American Indian/Alaska Native |
Male-to-male sexual contact |
59 |
64 |
|
446 |
56 |
Injection drug use |
10 |
11 |
|
91 |
11 |
Male-to-male sexual contact and injection drug use |
6 |
7 |
|
98 |
12 |
Hemophilia/coagulation disorder |
0 |
0 |
|
0 |
0 |
High-risk heterosexual contactb | 5 |
5 |
|
49 |
6 |
Sex with injection drug user |
1 |
1 |
|
13 |
2 |
Sex with person with hemophilia |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected transfusion recipient |
0 |
0 |
|
0 |
0 |
Sex with HIV-infected person, risk factor not specified |
4 |
4 |
|
36 |
5 |
Receipt of blood transfusion, blood components, or tissue |
0 |
0 |
|
2 |
0 |
Other/risk factor not reported or identified |
12 |
13 |
|
113 |
14 |
Total |
92 |
100 |
|
799 |
100 |
|
|
|
Total cases |
Male-to-male sexual contact |
12,730 |
51 |
|
84,500 |
49 |
Injection drug use |
2,611 |
11 |
|
21,718 |
13 |
Male-to-male sexual contact and injection drug use |
876 |
4 |
|
8,964 |
5 |
Hemophilia/coagulation disorder |
29 |
0 |
|
476 |
0 |
High-risk heterosexual contactb |
1,895 |
8 |
|
14,680 |
9 |
Sex with injection drug user |
228 |
1 |
|
2,408 |
1 |
Sex with person with hemophilia |
2 |
0 |
|
26 |
0 |
Sex with HIV-infected transfusion recipient |
10 |
0 |
|
127 |
0 |
Sex with HIV-infected person, risk factor not specified |
1,655 |
7 |
|
12,119 |
7 |
Receipt of blood transfusion, blood components, or tissue |
30 |
0 |
|
461 |
0 |
Other/risk factor not reported or identified |
6,560 |
27 |
|
40,370 |
24 |
Total |
24,731c |
100 |
|
171,169d |
100 |
|
|
|
Note. See
Table 16 for list of 38 states and U.S. dependent areas with confidential name-based HIV infection reporting as of December 2005. |
a |
From the beginning of the epidemic through December 2005. |
b |
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. |
c |
Includes 146 males of unknown race or multiple races. |
d |
Includes 1,543 males of unknown race or multiple races. |
|
Next: Table 21 |
|
|
|
|
|
|
|
|